应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。
关闭
02359 药明康德
休市中 07-24 16:08:05
157.400
-1.100
-0.69%
最高
161.200
最低
156.000
成交量
210.29万
今开
161.200
昨收
158.500
日振幅
3.28%
总市值
4,665亿
流通市值
771.26亿
总股本
29.64亿
成交额
3.32亿
换手率
0.43%
流通股本
4.90亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）
资讯
新帖
简况
每周股票复盘：机构净买入药明康德（603259）2447.04万元
证券之星 · 01:09
每周股票复盘：机构净买入药明康德（603259）2447.04万元
7月23日药明康德现1笔大宗交易 机构净买入2447.04万元
证券之星 · 07-23 18:04
7月23日药明康德现1笔大宗交易 机构净买入2447.04万元
小摩：在药明康德H股的持股比例升至11.39%
格隆汇 · 07-23 17:11
小摩：在药明康德H股的持股比例升至11.39%
港股直击 | 创新药板块走高，康方生物涨近7%，康诺亚-B、荣昌生物涨超3%
老虎资讯综合 · 07-23
港股直击 | 创新药板块走高，康方生物涨近7%，康诺亚-B、荣昌生物涨超3%
港股直击 | 生物医药股走强，康方生物涨近7%，荣昌生物涨超4%，泰格医药、诺诚健华涨近3%
老虎资讯综合 · 07-22
港股直击 | 生物医药股走强，康方生物涨近7%，荣昌生物涨超4%，泰格医药、诺诚健华涨近3%
异动解读｜药明康德盘中上涨3.16%，多家国际投行密集上调目标价叠加CXO板块持续回暖
行情直击 · 07-22
异动解读｜药明康德盘中上涨3.16%，多家国际投行密集上调目标价叠加CXO板块持续回暖
纪青2026年二季度表现，富安达上证科创板综合指数增强A基金季度涨幅43.19%
证券之星 · 07-21
纪青2026年二季度表现，富安达上证科创板综合指数增强A基金季度涨幅43.19%
药明康德（02359）将于2026年8月3日召开董事会审议中期业绩
公告速递 · 07-20
药明康德（02359）将于2026年8月3日召开董事会审议中期业绩
7月20日药明康德涨5.37%，医药ETF易方达基金重仓该股
证券之星 · 07-20
7月20日药明康德涨5.37%，医药ETF易方达基金重仓该股
药明康德涨5.37%，中邮证券二个月前给出“买入”评级
证券之星 · 07-20
药明康德涨5.37%，中邮证券二个月前给出“买入”评级
异动解读｜药明康德盘中上涨3.14%，生命科学板块集体反弹叠加多家投行密集上调目标价
行情直击 · 07-20
异动解读｜药明康德盘中上涨3.14%，生命科学板块集体反弹叠加多家投行密集上调目标价
每周股票复盘：药明康德（603259）一周两笔大宗交易超2400万
证券之星 · 07-19
每周股票复盘：药明康德（603259）一周两笔大宗交易超2400万
异动解读 | 药明康德盘中大跌5.12%，机构减持与板块走弱拖累股价
异动解读 · 07-17
异动解读 | 药明康德盘中大跌5.12%，机构减持与板块走弱拖累股价
异动解读｜药明康德盘中下跌3.15%，摩根大通减持多头仓位叠加板块集体走弱
行情直击 · 07-17
异动解读｜药明康德盘中下跌3.15%，摩根大通减持多头仓位叠加板块集体走弱
创新药连续大涨，这次真的不一样了吗？
华尔街见闻 · 07-16
创新药连续大涨，这次真的不一样了吗？
异动解读｜药明康德盘中下跌3.03%，报160.1港元
行情直击 · 07-16
异动解读｜药明康德盘中下跌3.03%，报160.1港元
港股概念追踪 | 实验猴身价飙升至20万！多家企业反映供不应求 CRO行业订单全面回暖(附概念股)
智通财经 · 07-16
港股概念追踪 | 实验猴身价飙升至20万！多家企业反映供不应求 CRO行业订单全面回暖(附概念股)
港股早盘高开高走 恒指半日涨1.46% 创新药、猪肉概念强势
金吾财讯 · 07-15
港股早盘高开高走 恒指半日涨1.46% 创新药、猪肉概念强势
大行评级丨瑞银：上调药明康德目标价至176.5港元，并列为行业首选
格隆汇 · 07-15
大行评级丨瑞银：上调药明康德目标价至176.5港元，并列为行业首选
【特约大V】邓声兴：美通胀骤降加息预期瓦解，恒指有望随外围强势反弹
金吾财讯 · 07-15
【特约大V】邓声兴：美通胀骤降加息预期瓦解，恒指有望随外围强势反弹
加载更多
公司概况
公司名称：
药明康德
所属市场：
SEHK
上市日期：
--
主营业务：
无锡药明康德新药开发股份有限公司是一家主要从事新药研发和生产服务业务的中国公司。该公司主要通过六个分部开展业务。化学业务分部主要从事提供新药研究、开发与生产服务。测试业务分部主要从事提供药品、医疗器械、体外诊断试剂服务。生物学业务分部主要从事提供药物发现及研究服务。高端治疗合同测试、研发与生产（CTDMO）业务分部主要从事为客户提供医疗产品工艺开发、生产和测试一体化服务。国内新药研发服务部分部主要从事为客户提供一体化新药研发服务。其他业务分部主要从事行政服务、销售原材料和销售废料业务。
发行价格：
--
{"stockData":{"symbol":"02359","market":"HK","secType":"STK","nameCN":"药明康德","latestPrice":157.4,"timestamp":1784880485006,"preClose":158.5,"halted":0,"volume":2102866,"delay":0,"changeRate":-0.006940063091482614,"floatShares":490000000,"shares":2964000000,"eps":7.651864471909408,"marketStatus":"休市中","change":-1.1,"latestTime":"07-24 16:08:05","open":161.2,"high":161.2,"low":156,"amount":332319562,"amplitude":0.032808,"askPrice":157.4,"askSize":900,"bidPrice":157.3,"bidSize":5800,"shortable":3,"etf":0,"ttmEps":7.991347947708524,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1785115800000},"marketStatusCode":7,"adr":0,"listingDate":1544630400000,"exchange":"SEHK","adjPreClose":158.5,"dividendRate":0.01421,"openAndCloseTimeList":[[1784856600000,1784865600000],[1784869200000,1784880000000]],"volumeRatio":0.33149835803110594,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD","optionSymbol":"WXA.HK","astockBrief":{"symbol":"603259","market":"SH","secType":"STK","nameCN":"药明康德","latestPrice":125,"timestamp":1784876400000,"preClose":127.45,"halted":0,"volume":44375500,"delay":0,"premium":"+8.77"},"impliedVol":0.5853,"impliedVolPercentile":0.952},"requestUrl":"/m/hq/s/02359","defaultTab":"news","newsList":[{"id":"2654052323","title":"每周股票复盘：机构净买入药明康德（603259）2447.04万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2654052323","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2654052323?lang=zh_cn&edition=full","pubTime":"2026-07-26 01:09","pubTimestamp":1784999351,"startTime":"0","endTime":"0","summary":"截至2026年7月24日收盘，药明康德报收于125.0元，较上周的117.89元上涨6.03%。本周，药明康德7月22日盘中最高价报130.9元。药明康德当前最新总市值3729.7亿元，在医疗服务板块市值排名1/51，在两市A股市值排名36/5200。来自公司公告汇总：药明康德将于2026年8月3日召开董事会，审议中期业绩及中期股息派发事项。交易信息汇总7月23日药明康德发生1笔大宗交易，机构净买入2447.04万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072600000077.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1997245177.USD","LU1046422090.SGD","LU2242644610.SGD","IE00B5MMRT66.SGD","LU1808992512.USD","LU1934453819.USD","LU1979443071.USD","LU2045819591.USD","LU0611395673.USD","LU1770034418.SGD","LU1997244956.HKD","LU0348767384.USD","LU1719994722.HKD","IE00B543WZ88.USD","LU1969619763.USD","BK0216","LU2125910500.SGD","LU2328871848.SGD","LU0320764599.SGD","LU1251922891.USD","LU1303224171.USD","LU2488822045.USD","LU1997245094.SGD","LU0708995583.HKD","BK1583","IE00BPRC5H50.USD","LU0456842615.SGD","LU2495084118.USD","02359","LU0348766576.USD","BK1141","BK1576","603259","LU0052750758.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653746915","title":"7月23日药明康德现1笔大宗交易 机构净买入2447.04万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2653746915","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2653746915?lang=zh_cn&edition=full","pubTime":"2026-07-23 18:04","pubTimestamp":1784801075,"startTime":"0","endTime":"0","summary":"证券之星消息，7月23日药明康德发生大宗交易，交易数据如下：大宗交易成交价格127.45元，成交19.2万股，成交金额2447.04万元，买方营业部为机构专用，卖方营业部为中信证券股份有限公司总部。近三个月该股共发生13笔大宗交易，合计成交5.68万手，折价成交1笔。截至2026年7月23日收盘，药明康德报收于127.45元，上涨1.23%，换手率1.89%，成交量46.84万手，成交额59.32亿元。本文数据来源于上海证券交易所大宗交易信息披露，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072300037222.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU0611395673.USD","LU2242644610.SGD","LU1979443071.USD","LU1997245094.SGD","LU0348766576.USD","LU0348767384.USD","BK1583","LU1808992512.USD","LU0320764599.SGD","LU1719994722.HKD","LU2495084118.USD","IE00B543WZ88.USD","603259","02359","IE00BPRC5H50.USD","LU0052750758.USD","LU2488822045.USD","LU1046422090.SGD","LU1997245177.USD","LU1997244956.HKD","IE00B5MMRT66.SGD","LU0456842615.SGD","LU1969619763.USD","LU0708995583.HKD","LU2328871848.SGD","LU2045819591.USD","LU1251922891.USD","LU2125910500.SGD","BK0216","LU1770034418.SGD","BK1576","LU1303224171.USD","LU1934453819.USD","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653642743","title":"小摩：在药明康德H股的持股比例升至11.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2653642743","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2653642743?lang=zh_cn&edition=full","pubTime":"2026-07-23 17:11","pubTimestamp":1784797901,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU1046422090.SGD","LU0348766576.USD","LU0348767384.USD","LU2125910500.SGD","LU0708995583.HKD","LU2242644610.SGD","LU2045819591.USD","BK1583","BK1141","LU0320764599.SGD","LU0052750758.USD","BK1576","02359"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131916151","title":"港股直击 | 创新药板块走高，康方生物涨近7%，康诺亚-B、荣昌生物涨超3%","url":"https://stock-news.laohu8.com/highlight/detail?id=1131916151","media":"老虎资讯综合","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1131916151?lang=zh_cn&edition=full","pubTime":"2026-07-23 13:46","pubTimestamp":1784785579,"startTime":"0","endTime":"0","summary":"7月23日，创新药板块走高，康方生物涨近7%，康诺亚-B、荣昌生物涨超3%，恒瑞医药、药明康德涨超2%，药明生物涨近2%。消息面上，康诺亚-B公告称，公司重点研发产品CM512（TSLP/IL-13双抗）已被国家药监局药审中心纳入突破性治疗品种名单，拟用于治疗慢性鼻窦炎伴鼻息肉。CM512为公司自主研发的IgG-like长效型TSLPxIL-13双阻断剂，此前I期临床研究已于2025年11月达成全部研究终点，并于2026年4月在《Journal of Translational Medicine》发表相关结果。目前，CM512用于慢性鼻窦炎伴鼻息肉的II期临床研究正在推进，公司同时布局中重度哮喘、中重度慢阻肺、成人中重度特应性皮炎、慢性自发性荨麻疹等多个适应症。","market":"hk","thumbnail":"https://static.tigerbbs.com/df4ec61541b268a5353585001973d7cb","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/df4ec61541b268a5353585001973d7cb"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02162","01276","09926","02269","02359","09995"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145405224","title":"港股直击 | 生物医药股走强，康方生物涨近7%，荣昌生物涨超4%，泰格医药、诺诚健华涨近3%","url":"https://stock-news.laohu8.com/highlight/detail?id=1145405224","media":"老虎资讯综合","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1145405224?lang=zh_cn&edition=full","pubTime":"2026-07-22 10:11","pubTimestamp":1784686287,"startTime":"0","endTime":"0","summary":"7月22日，港股生物医药股走强，康方生物涨近7%，荣昌生物涨超4%，泰格医药、诺诚健华涨近3%，复宏汉霖、药明康德、君实生物涨超2%。消息面上，美国总统特朗普当地时间7月21日在社交媒体发文表示，自2026.8.1起，所有进口到美国的仿制药将在未来两年内继续适用零关税。两年期满后，相关产品将被征收100%的关税，期限为一年。此后，关税将进一步提高至200%。","market":"hk","thumbnail":"https://static.tigerbbs.com/abf9f2b56caccf2c92db82642df48d35","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/abf9f2b56caccf2c92db82642df48d35"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":"港股直击 | 生物医药股走强，康方生物涨近7%，荣昌生物涨超4%，泰格医药、诺诚健华涨近3%","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03347","02359","09995","09926","01877","02696","09969"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1190805301","title":"异动解读｜药明康德盘中上涨3.16%，多家国际投行密集上调目标价叠加CXO板块持续回暖","url":"https://stock-news.laohu8.com/highlight/detail?id=1190805301","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1190805301?lang=zh_cn&edition=full","pubTime":"2026-07-22 09:52","pubTimestamp":1784685161,"startTime":"0","endTime":"0","summary":"7月22日，药明康德盘中上涨3.16%，报163.2港元/股，成交额2.41亿港元。消息面上，近期多家国际投行密集上调药明康德目标价，瑞银上调至176.5港元并列为行业首选，大和大幅上调至190港元，摩根士丹利上调至168港元并重申首选股地位，形成看多合力。基本面上，公司一季度在手订单达597.7亿元，同比增长23.6%，TIDES业务客户数与服务分子数分别增长28%及59%，机构预计CXO反弹有望获得业绩支撑。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02359"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653090842","title":"纪青2026年二季度表现，富安达上证科创板综合指数增强A基金季度涨幅43.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2653090842","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2653090842?lang=zh_cn&edition=full","pubTime":"2026-07-21 23:53","pubTimestamp":1784649183,"startTime":"0","endTime":"0","summary":"证券之星消息，截止2026年二季度末，基金经理纪青旗下共管理9只基金，本季度表现最佳的为富安达上证科创板综合指数增强A，季度净值涨43.19%。持有期间的估算收益率为98.33%，持有期间紫金矿业在2024年到2025年的年报归属净利润增幅达61.55%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072100046086.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0015","LU1997244956.HKD","LU1781817850.SGD","BK0028","LU0164865239.USD","LU1997245177.USD","LU2148510915.USD","LU1064131003.USD","LU1934453819.USD","LU0651946864.USD","BK0127","BK0242","IE00B5MMRT66.SGD","LU0611395673.USD","LU0871576103.HKD","LU1808992512.USD","LU2488822045.USD","LU2289578879.USD","LU0898667661.SGD","LU2495084118.USD","LU2580892862.HKD","HK0000181138.USD","BK0196","LU0117844026.USD","ZIJMY","LU1655091459.SGD","300014","LU0651947912.USD","603259","LU0831103253.SGD","IE00B543WZ88.USD","EVS.SI","02899","BK0012","LU2328871848.SGD","BK0216","LU1064130708.USD","HK0000181112.HKD","LU0456842615.SGD","BK0077","LU0210527791.USD","HK0000151867.HKD","LU1051769294.HKD","LU1719994722.HKD","BK0201","LU1580142542.USD","LU1770034418.SGD","LU1303224171.USD","LU0784639295.USD","LU1969619763.USD","LU1979443071.USD","LU0039217434.USD","BK0183","LU1997245094.SGD","SGXZ49509284.SGD","LU1255011170.USD","02359","LU0531971595.HKD","BK0132","BK0070","601899","BK0155","LU1655091616.SGD","LU1051768304.USD","LU1251922891.USD","LU1515016050.SGD","BK0224","LU2580892789.USD","SGXZ81163826.USD","IE00BPRC5H50.USD","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1156161229","title":"药明康德（02359）将于2026年8月3日召开董事会审议中期业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=1156161229","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1156161229?lang=zh_cn&edition=full","pubTime":"2026-07-20 16:35","pubTimestamp":1784536546,"startTime":"0","endTime":"0","summary":"无锡药明康德新药开发股份有限公司（02359）7月20日公告，公司董事会定于2026年8月3日（星期一）召开会议，主要议程包括：1）审议并批准集团截至2026年6月30日止六个月的未经审计中期业绩及其发布；2）商讨建议派发中期股息（如有）；3）处理其他相关事项。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02359"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652295285","title":"7月20日药明康德涨5.37%，医药ETF易方达基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2652295285","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2652295285?lang=zh_cn&edition=full","pubTime":"2026-07-20 16:19","pubTimestamp":1784535546,"startTime":"0","endTime":"0","summary":"证券之星消息，7月20日药明康德涨5.37%，收盘报124.22元，换手率2.8%，成交量69.19万手，成交额84.85亿元。根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共629家，其中持有数量最多的公募基金为易方达基金的医药ETF易方达。医药ETF易方达目前规模为172.15亿元，最新净值0.3629，较上一交易日下跌4.2%，近一年下跌6.18%。医药ETF易方达的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072000024266.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["IE00BPRC5H50.USD","LU2488822045.USD","LU0611395673.USD","IE00B543WZ88.USD","LU0348767384.USD","LU1934453819.USD","LU1997244956.HKD","LU2242644610.SGD","BK0216","LU1969619763.USD","LU1719994722.HKD","LU2125910500.SGD","LU1997245177.USD","LU1046422090.SGD","LU1808992512.USD","LU1251922891.USD","LU0320764599.SGD","LU0052750758.USD","LU1997245094.SGD","LU0456842615.SGD","LU0708995583.HKD","LU1770034418.SGD","LU2328871848.SGD","BK1576","LU1979443071.USD","LU1303224171.USD","512010","IE00B5MMRT66.SGD","LU0348766576.USD","603259","BK1583","LU2045819591.USD","02359","BK1141","LU2495084118.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652295254","title":"药明康德涨5.37%，中邮证券二个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2652295254","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2652295254?lang=zh_cn&edition=full","pubTime":"2026-07-20 16:18","pubTimestamp":1784535533,"startTime":"0","endTime":"0","summary":"今日药明康德涨5.37%，收盘报124.22元。2026年5月20日，中邮证券研究员盛丽华,辛家齐发布了对药明康德的研报《业绩加速释放，三大板块盈利能力齐升》，该研报对药明康德给出“买入”评级。公司是一站式端到端的医药研发外包企业龙头，维持“买入”评级。证券之星数据中心计算显示，对该股盈利预测较准的分析师团队为浦银国际证券的丁政宁。药明康德个股概况：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072000024264.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603259","02359","161027"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111150919","title":"异动解读｜药明康德盘中上涨3.14%，生命科学板块集体反弹叠加多家投行密集上调目标价","url":"https://stock-news.laohu8.com/highlight/detail?id=1111150919","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1111150919?lang=zh_cn&edition=full","pubTime":"2026-07-20 10:05","pubTimestamp":1784513153,"startTime":"0","endTime":"0","summary":"7月20日，药明康德盘中上涨3.14%，报158.6港元/股，成交额3.42亿港元。消息面上，此前瑞银将药明康德目标价上调至176.5港元并列为行业首选，大和大幅上调目标价至190港元，摩根士丹利亦上调目标价至168港元并重申首选股地位，多家国际投行密集看好形成合力。此外，CXO板块在业绩和订单支撑下整体回暖，生命科学工具和服务板块今日集体走强，康龙化成涨5.78%，昭衍新药涨5.56%，药明合联涨5.44%，英矽智能涨4.81%，药明生物涨4.54%，板块联动效应明显。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02359"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652237506","title":"每周股票复盘：药明康德（603259）一周两笔大宗交易超2400万","url":"https://stock-news.laohu8.com/highlight/detail?id=2652237506","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2652237506?lang=zh_cn&edition=full","pubTime":"2026-07-19 01:02","pubTimestamp":1784394129,"startTime":"0","endTime":"0","summary":"截至2026年7月17日收盘，药明康德报收于117.89元，较上周的123.3元下跌4.39%。本周，药明康德7月15日盘中最高价报135.17元，股价触及近一年最高点。7月17日盘中最低价报117.7元。药明康德当前最新总市值3517.55亿元，在医疗服务板块市值排名1/51，在两市A股市值排名38/5199。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071900000043.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["IE00B543WZ88.USD","BK0216","LU2328871848.SGD","LU1997245177.USD","LU0456842615.SGD","LU2488822045.USD","LU0348767384.USD","LU0708995583.HKD","LU1997245094.SGD","LU0348766576.USD","02359","LU2125910500.SGD","LU2045819591.USD","LU1719994722.HKD","LU2242644610.SGD","LU0052750758.USD","603259","LU1934453819.USD","BK1141","BK1583","BK1576","LU1969619763.USD","IE00BPRC5H50.USD","LU0611395673.USD","LU1303224171.USD","LU1808992512.USD","IE00B5MMRT66.SGD","LU1046422090.SGD","LU1997244956.HKD","LU1770034418.SGD","LU1251922891.USD","LU0320764599.SGD","LU1979443071.USD","LU2495084118.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164293764","title":"异动解读 | 药明康德盘中大跌5.12%，机构减持与板块走弱拖累股价","url":"https://stock-news.laohu8.com/highlight/detail?id=1164293764","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1164293764?lang=zh_cn&edition=full","pubTime":"2026-07-17 10:14","pubTimestamp":1784254497,"startTime":"0","endTime":"0","summary":"药明康德今日盘中股价出现大幅下跌，跌幅达到5.12%，市场关注度显著提升。消息面上，此次下跌主要受到多重因素影响。根据港交所披露的信息，摩根大通对药明康德H股的多头持仓比例有所下降，从11.08%降至10.89%，这释放了机构投资者减仓的信号，对市场情绪产生负面影响。与此同时，整个生命科学工具和服务板块今日表现疲软，相关个股普遍下跌，进一步拖累了药明康德的股价。此外，分析指出，药明康德股价在前期因多家投行上调目标价而连续走强，积累了较大的涨幅，短期内存在获利回吐的压力。机构减持、板块整体承压以及技术性调整需求共同导致了股价的盘中大跌。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02359"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191118815","title":"异动解读｜药明康德盘中下跌3.15%，摩根大通减持多头仓位叠加板块集体走弱","url":"https://stock-news.laohu8.com/highlight/detail?id=1191118815","media":"行情直击","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1191118815?lang=zh_cn&edition=full","pubTime":"2026-07-17 10:10","pubTimestamp":1784254253,"startTime":"0","endTime":"0","summary":"7月17日，药明康德盘中下跌3.15%，报154.8港元/股，成交额5.16亿港元。消息面上，港交所披露摩根大通对药明康德H股多头持仓比例从11.08%降至10.89%，释放机构减仓信号。与此同时，生命科学工具和服务板块集体承压，昭衍新药跌8.52%，英矽智能跌8.2%，药明合联跌6.41%，晶泰控股跌5.4%，药明生物跌4.02%。此前该股在多家投行密集上调目标价带动下连续走强，短期获利回吐压力显现。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02359"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651341039","title":"创新药连续大涨，这次真的不一样了吗？","url":"https://stock-news.laohu8.com/highlight/detail?id=2651341039","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651341039?lang=zh_cn&edition=full","pubTime":"2026-07-16 17:05","pubTimestamp":1784192720,"startTime":"0","endTime":"0","summary":"政策上，医保初审通过率创新高，定价机制优化，并建立“医保+商保”双层支付体系；产业上，上半年BD交易总额达1100亿美元，国际竞争力显著提升；资金面上，内外资持续回流。行业正从“讲故事”转向盈利兑现，国金证券认为，2027年有望成为中国创新药海外商业化集中兑现的重要节点。","market":"hk","thumbnail":"https://static.tigerbbs.com/8daedf52c02cecfd417dcbd813afb3fa","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/8daedf52c02cecfd417dcbd813afb3fa"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3777107","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159992","06978","02268","06622","06606","03759","IBBQ","01801","BK1574","BK1161","02269","02137","09688","00241","09995","06996","03347","06618","01672","09606","02359","09966","MEDX"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1185461751","title":"异动解读｜药明康德盘中下跌3.03%，报160.1港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1185461751","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1185461751?lang=zh_cn&edition=full","pubTime":"2026-07-16 14:39","pubTimestamp":1784183977,"startTime":"0","endTime":"0","summary":"7月16日，药明康德盘中下跌3.03%，报160.1港元/股，成交额7.9亿港元。药明康德所在的生命科学工具和服务行业中，板块整体走弱，个股中，昭衍新药跌8.08%，药明合联跌7.02%，英矽智能跌2.63%，药明生物跌1.47%，晶泰控股涨0.89%。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02359"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651945934","title":"港股概念追踪 | 实验猴身价飙升至20万！多家企业反映供不应求 CRO行业订单全面回暖(附概念股)","url":"https://stock-news.laohu8.com/highlight/detail?id=2651945934","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651945934?lang=zh_cn&edition=full","pubTime":"2026-07-16 07:49","pubTimestamp":1784159344,"startTime":"0","endTime":"0","summary":"当前，整个CRO行业正处于订单全面回暖的上行期。药明康德、康龙化成、益诺思、昭衍新药等多家头部CRO企业2026年一季度新签订单普遍实现大幅增长。截至一季度末，在手订单约31亿元，同比增长40.9%。对于2026年，药明康德此前预计，2026全年整体收入达513亿元至530亿元；持续经营业务收入同比增长18%至22%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1468210.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","SG9999002463.SGD","LU0708995583.HKD","LU0456846285.SGD","LU0052750758.USD","LU0516422366.SGD","LU0043850808.USD","LU0516423174.USD","BK4588","06127","LU0823426480.USD","LU0516422952.EUR","LU0456827905.SGD","LU3063872942.SGD","LU2045819591.USD","02269","LU0140636845.USD","LU0819121731.USD","LU0181495838.USD","LU0979878070.USD","LU1720050803.USD","IE00B0JY6N72.USD","BK1610","SG9999002562.SGD","LU0359202008.SGD","LU0823426308.USD","LU1880383366.USD","KCAI","LU0348825331.USD","LU0572944931.SGD","LU0359201612.USD","BK1589","03759","LU0326950275.SGD","VXUS","KURE","LU0320764599.SGD","BK1521","LU0417516902.SGD","LU0348766576.USD","BK1576","LU1046422090.SGD","LU1794554557.SGD","LU0856984785.SGD","LU0039217434.USD","LU0348767384.USD","LU1242518857.USD","BK1141","LU0307460666.USD","02359"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651810439","title":"港股早盘高开高走 恒指半日涨1.46% 创新药、猪肉概念强势","url":"https://stock-news.laohu8.com/highlight/detail?id=2651810439","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651810439?lang=zh_cn&edition=full","pubTime":"2026-07-15 12:11","pubTimestamp":1784088667,"startTime":"0","endTime":"0","summary":"金吾财讯 | 港股早盘高开高走，三大股指均升逾1%。截至午间收盘，恒生指数上涨1.46%；国企指数涨1.16%；恒生科技指数涨1.39%。猪价底部大概率已现，预计周期临近上行。预计2026年半年度归属于上市公司股东的扣除非经常性损益的净利润约为人民币20.00亿元到人民币26.00亿元，与上年同期相比，将增加人民币18.62亿元到人民币24.62亿元，同比增长1349%到1784%。MiniMax盘中反复拉升，午间收涨14.96%。港股将受益于中国内地强劲而有韧性的经济表现，建议超配H股。","market":"us","thumbnail":"https://static.szfiu.com/news/20241108/YWY0NWM4YTUxZGFlZmZjNmE5MDYxNjI4NjU1Mjc3NzM1Mzg=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/YWY0NWM4YTUxZGFlZmZjNmE5MDYxNjI4NjU1Mjc3NzM1Mzg=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1985921","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0880133367.SGD","82800","LU0326950275.SGD","LU1048596156.SGD","LU1794554557.SGD","00386","83115","BK1576","LU1048588211.SGD","01477","LU0072913022.USD","LU0405327148.USD","03115","LU1242518931.SGD","LU0823426480.USD","SG9999001226.SGD","LU2097828714.EUR","LU0540923850.HKD","LU0865486749.SGD","688981","LU0169518387.USD","SGXZ62798434.SGD","LU0251144936.SGD","LU0359201885.HKD","00100","LU2257852520.SGD","IE00BZ08YS42.EUR","LU0469268626.HKD","LU0348784397.USD","IE00BQJZWZ67.USD","06990","02269","BK1149","BK1191","LU1282651121.HKD","LU1720050803.USD","BK1603","01928","LU1634259391.SGD","SG9999001093.SGD","LU0441854154.USD","LU1961090484.USD","LU0708995583.HKD","LU2328871848.SGD","LU0455707207.USD","LU0405327494.USD","BK1550","BK1526","IE00B5MMRT66.SGD","LU0463099449.HKD","LU2399975544.HKD","01093","BK1172","IE00B543WZ88.USD","BK1184","IE00B0JY6N72.USD","SG9999012710.SGD","LU0314109678.HKD","LU0823426308.USD","LU0456846285.SGD","LU0588545904.SGD","LU0348825331.USD","LU0501845795.SGD","BK1515","LU0561508036.HKD","002714","LU1688375341.USD","SG9999012728.SGD","KURE","LU1808992512.USD","LU1770034418.SGD","BK1589","06869","LU2097828474.EUR","LU1497733631.SGD","LU1993786604.SGD","HSI","LU0516422440.USD","LU1051768304.USD","BK1549","LU0611395673.USD","LU1831875114.USD","LU2125910500.SGD","BK1574","LU2293587155.HKD","LU1251922891.USD","BK1583","IE00BZ08YR35.GBP","LU2097828805.USD","LU0048597586.USD","LU0651947912.USD","LU0348766576.USD","SG9999003461.SGD","LU0856984785.SGD","BK1521","BK1226","IE00BZ08YT58.USD","LU1115378108.SGD","LU0531971595.HKD","BK1523","LU0287142896.SGD","LU1807302812.USD","LU1880383366.USD","601857","BK1161","603259","01801","HSTECH","LU1226288253.USD","LU0348783233.USD","LU0140636845.USD","LU1960683339.HKD","LU0228367735.SGD","LU1497734951.SGD","09926","IE00BWDBJ730.SGD","LU1226287529.USD","SG9999002463.SGD","LU1675838814.USD","01610","LU2242644610.SGD","LU0675040207.SGD","LU1282651048.USD","LU0348827113.USD","LU1046422090.SGD","BK1163","BK1237","IE0032431581.USD","LU0315179316.USD","LU0348783662.USD","LU0072462343.USD","LU1226287792.SGD","LU1008478684.HKD","LU1023057109.AUD","LU0828237940.HKD","LU2045819591.USD","LU1522347837.USD","LU1719994722.HKD","LU1226287875.USD","09115","LU2476274720.SGD","IE00B19Z5X02.USD","LU0634319403.HKD","LU0819121731.USD","HK0000286598.CNH","BK1614","BK1610","SGXZ86797644.SGD","LU2476274308.USD","BK1117","LU2488822045.USD","LU0588546209.SGD","LU2778985437.USD","00981","LU0211977185.USD","LU1211504680.USD","03419","LU2097828557.USD","LU0043850808.USD","SG9999012744.USD","SG9999002562.SGD","LU0588545730.USD","LU0516423174.USD","LU0181495838.USD","07200","MCHmain","LU0244354667.USD","LU0052750758.USD","LU0327786744.USD","LU0051755006.USD","LU0821914370.USD","LU0516422952.EUR","LU2097828631.EUR","LU0320764599.SGD","LU0417516571.SGD","LU1328277881.USD","LU0456827905.SGD","HK0000165453.HKD","LU1951186391.HKD","IE0008369823.USD","LU1969619763.USD","02359","HHImain","LU3063872942.SGD","IE00B031HY20.USD","IE00BPRC5H50.USD","LU1813983027.USD","LU0348735423.USD","02419","02714","LU0039217434.USD","SG9999004220.SGD","SG9999012736.USD","01177","BK1528","02628","LU1188198961.HKD","07500","LU0164865239.USD","SBHMY","LU0359202008.SGD","LU0516423091.SGD","LU0871576103.HKD","LU1785774172.SGD","LU0315178854.USD","LU1497733557.USD","02268","03037","LU0640798160.USD","00857","LU0417516738.SGD","LU0572944931.SGD","LU1303224171.USD","LU1051769294.HKD","LU0862451753.SGD","LU0359201612.USD","BK1607","LU0979878070.USD","LU2039709279.SGD","LU0348805143.USD","LU0588545490.SGD","513600","600028","07300","LU0651946864.USD","LU0890818403.SGD","LU1152091168.USD","LU1242518857.USD","SCHYY","LU0163747925.USD","LU0862451837.USD","LU1152091754.HKD","SG9999014674.SGD","LU0173614495.USD","LU0196878994.USD","LU0307460666.USD","LU0516422366.SGD","02800","BK1506","LU0067412154.USD","BK1584","BK1562","IE0008368742.USD","WXXWY","LU0972618739.USD","LU1226288170.HKD","LU0417516902.SGD","LU1634259557.SGD","LU0293314216.USD","BK1141","601869","LU1224444064.USD","601628","LU0502904849.HKD","02833","LU1515016050.SGD","SG9999006597.SGD","LU0348767384.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651435143","title":"大行评级丨瑞银：上调药明康德目标价至176.5港元，并列为行业首选","url":"https://stock-news.laohu8.com/highlight/detail?id=2651435143","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651435143?lang=zh_cn&edition=full","pubTime":"2026-07-15 11:03","pubTimestamp":1784084588,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK1583","LU2242644610.SGD","LU0052750758.USD","LU1303224171.USD","LU0708995583.HKD","LU2488822045.USD","LU1934453819.USD","IE00B5MMRT66.SGD","LU2495084118.USD","LU1997244956.HKD","LU1251922891.USD","LU1719994722.HKD","BK0216","LU2045819591.USD","BK1141","LU1979443071.USD","LU1969619763.USD","02359","LU1808992512.USD","LU1046422090.SGD","LU2125910500.SGD","LU2328871848.SGD","LU1997245177.USD","LU1997245094.SGD","LU0320764599.SGD","LU0456842615.SGD","LU0348767384.USD","IE00B543WZ88.USD","603259","IE00BPRC5H50.USD","BK1576","LU0348766576.USD","LU1770034418.SGD","LU0611395673.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651768433","title":"【特约大V】邓声兴：美通胀骤降加息预期瓦解，恒指有望随外围强势反弹","url":"https://stock-news.laohu8.com/highlight/detail?id=2651768433","media":"金吾财讯","labels":["economic"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651768433?lang=zh_cn&edition=full","pubTime":"2026-07-15 10:20","pubTimestamp":1784082018,"startTime":"0","endTime":"0","summary":"中国铝业预计2026年上半年归属股东净利润112亿至122亿元人民币，按年增58%至73%，股价升9.6%，报8.23元，是表现最好蓝筹。美通胀骤降加息预期瓦解，恒指有望随外围强势反弹。药明康德正处于早期研发弱复苏与商业化生产强劲的双重周期交汇点，GLP-1相关订单能见度高企，回购行动亦为股价提供底部支撑，中线估值修复空间值得投资者留意。","market":"hk","thumbnail":"https://static.szfiu.com/news/20241108/ZjAzYmQ0ZTAxMjgwMmU1OWFmMjcwNDc3NDA4NDI=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/ZjAzYmQ0ZTAxMjgwMmU1OWFmMjcwNDc3NDA4NDI=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1985899","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"economic","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1576","03037","601600","83115","HSTECH","BK1141","02833","02800","02600","513600","MCHmain","07300","BK1568","HK0000286598.CNH","LU2242644610.SGD","HHImain","LU0320764599.SGD","LU0348766576.USD","02359","603259","03115","LU2125910500.SGD","BK1175","LU0348767384.USD","BK1583","HSI","BK1592","03419","BK1513","LU1046422090.SGD","LU0708995583.HKD","82800","07200","LU0052750758.USD","LU2045819591.USD","LU1808992512.USD","09115","07500"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.wuxiapptec.com.cn","stockEarnings":[{"period":"1week","weight":0.0288},{"period":"1month","weight":0.1108},{"period":"3month","weight":0.2892},{"period":"6month","weight":0.3977},{"period":"1year","weight":0.6582},{"period":"ytd","weight":0.6158}],"compareEarnings":[{"period":"1week","weight":0.0163},{"period":"1month","weight":0.0662},{"period":"3month","weight":-0.0391},{"period":"6month","weight":-0.0668},{"period":"1year","weight":-0.0274},{"period":"ytd","weight":-0.026}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"无锡药明康德新药开发股份有限公司是一家主要从事新药研发和生产服务业务的中国公司。该公司主要通过六个分部开展业务。化学业务分部主要从事提供新药研究、开发与生产服务。测试业务分部主要从事提供药品、医疗器械、体外诊断试剂服务。生物学业务分部主要从事提供药物发现及研究服务。高端治疗合同测试、研发与生产（CTDMO）业务分部主要从事为客户提供医疗产品工艺开发、生产和测试一体化服务。国内新药研发服务部分部主要从事为客户提供一体化新药研发服务。其他业务分部主要从事行政服务、销售原材料和销售废料业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.026729},{"month":2,"riseRate":0.5,"avgChangeRate":0.002975},{"month":3,"riseRate":0.375,"avgChangeRate":-0.010736},{"month":4,"riseRate":0.5,"avgChangeRate":0.006503},{"month":5,"riseRate":0.375,"avgChangeRate":-0.004537},{"month":6,"riseRate":0.75,"avgChangeRate":0.08954},{"month":7,"riseRate":0.75,"avgChangeRate":0.089731},{"month":8,"riseRate":0.571429,"avgChangeRate":0.042301},{"month":9,"riseRate":0.571429,"avgChangeRate":0.088071},{"month":10,"riseRate":0.428571,"avgChangeRate":-0.002332},{"month":11,"riseRate":0.285714,"avgChangeRate":-0.00294},{"month":12,"riseRate":0.571429,"avgChangeRate":0.038239}],"exchange":"SEHK","name":"药明康德","nameEN":"WUXI APPTEC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"药明康德(02359)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供药明康德(02359)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"药明康德,02359,药明康德股票,药明康德股票老虎,药明康德股票老虎国际,药明康德行情,药明康德股票行情,药明康德股价,药明康德股市,药明康德股票价格,药明康德股票交易,药明康德股票购买,药明康德股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"药明康德(02359)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供药明康德(02359)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}